Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Arthur T. Sands, M.D., Ph.D., Lexicon's president and chief executive officer, will present at the 2012 BIO CEO & Investor Conference in New York on Tuesday, February 14, 2012 at 10:00 a.m. Eastern Time. At the conference, which is hosted by the Biotechnology Industry Organization (BIO), Dr. Sands will provide an overview on Lexicon's clinical development programs and milestones.
A live webcast of the presentation will be available through Lexicon's ...
read more